China-incorporated Fenglin, the administrative arm of the Shanghai Xuhui government in charge of life sciences, aims to establish an integrated ecosystem of local and international stakeholders in Shanghai’s Xuhui District to accelerate biopharmaceutical innovation and development.
AcroMeta Group's (SGX:43F
) 70% owned subsidiary Life Science Incubator Holdings (LSI) has signed two memoranda of understanding (MOUs) to develop its co-working laboratory space business in China.
LSI has firstly entered into a strategic partnership with Fenglin Healthcare Industry Development Group through a non-binding to develop new business opportunities for co-working laboratory space in China.
